CAS 1807758-81-1

SIRT7 inhibitor 97491

CAS: 1807758-81-1

SIRT7 inhibitor 97491

Purity: ≥98%

Molecular weight: 285.73g/mol

Ref: 54-BUP02940

Sirt7 inhibitor 97491

CAS: 1807758-81-1

Sirt7 inhibitor 97491 is an anticancer drug that works by inhibiting the activity of Sirt7, a protein that promotes tumor growth. This inhibitor has been shown to be effective in human cancer cell lines and may have potential for use in cancer therapy. The drug has been tested in Chinese hamster ovary cells and was found to induce apoptosis, or programmed cell death, in these cells. Sirt7 inhibitor 97491 is an analog of chloroquine and can also inhibit kinases, which are enzymes involved in signaling pathways that regulate cell growth and division. In addition, this inhibitor has been found to increase the effectiveness of other anticancer drugs such as artesunate. Overall, Sirt7 inhibitor 97491 is a promising new drug candidate for the treatment of cancer.

Formula: C₁₅H₁₂ClN₃O

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 285.73 g/mol

Ref: 3D-HXC75881

SIRT7 inhibitor 97491

CAS: 1807758-81-1

SIRT7 inhibitor 97491 is an HDAC inhibitor with high specificity for SIRT7 (IC50 = 325 nM). SIRT7 inhibitor 97491 promotes apoptosis through caspase pathway.

Formula: C₁₅H₁₂ClN₃O

Purity: 99.79%

Color and Shape: Solid

Molecular weight: 285.73

Ref: TM-T39233

N1-(5-(4-Chlorophenyl)oxazol-2-yl)benzene-1,3-diamine

CAS: 1807758-81-1

Formula: C₁₅H₁₂ClN₃O

Purity: 97%

Color and Shape: Solid

Molecular weight: 285.7283

Ref: IN-DA01V51B